CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer
Protein kinase CK2 demonstrates increased protein expression relative to non-transformed cells in the majority of cancers that have been examined. The elevated levels of CK2 are involved in promoting not only continued proliferation of cancer cells but also their resistance to cell death; thus, CK2...
Saved in:
Main Authors: | Janeen H. Trembley (Author), Betsy T. Kren (Author), Md. Joynal Abedin (Author), Rachel I. Vogel (Author), Claire M. Cannon (Author), Gretchen M. Unger (Author), Khalil Ahmed (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers
by: Betsy T. Kren, et al.
Published: (2024) -
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
by: Janeen H. Trembley, et al.
Published: (2019) -
CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
by: Rehana L. Ahmed, et al.
Published: (2019) -
Comparing the Diagnostic Outcomes of Staining Various Breast Lesions with Either Anti-CK 5/6 or Anti-CK 5
by: Mihir A Gudi, et al.
Published: (2019) -
Right on target: The next class of efficient, safe, and specific RNAi triggers
by: Jonas Becker, et al.
Published: (2022)